Institute of Biomedical Research Corp. MRES OTC

Other OTC • Healthcare • Biotechnology • ME • USD

SharesGrow Score

42/100

1/5 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Institute of Biomedical Research Corp. (MRES) .

Criteria proven by this page:

VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.

Overall SharesGrow Score: 40/100 with 1/7 criteria passed.

SharesGrow 7-Criteria Score

42/100

SG Score

View full scorecard →

—

VALUE

N/A

No coverage

—

FUTURE

N/A

No coverage

✗

PAST

25/100

→ Income

✗

HEALTH

33/100

Debt-to-Equity & liquidity

→ Health

✗

MOAT

43/100

→ Income

✓

GROWTH

100/100

→ Income

✗

INCOME

10/100

→ Income

Valuation Snapshot — MRES

Valuation Multiples

P/E (TTM)0.0

Forward P/EN/A

PEG RatioN/A

Forward PEGN/A

P/B Ratio0.00

P/S Ratio113.03

EV/EBITDA0.0

Per Share Data

EPS (TTM)$0.00

Book Value / Share$0.00

Revenue / Share$0.00

FCF / Share$0.00

Yields & Fair Value

Earnings YieldN/A

Dividend Yield0.00%

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year	EPS (Diluted)	Revenue	Net Income	Net Margin
2006	$-0.13	$0.00	$-176.88K	-
2007	$-0.39	$0.00	$-690.3K	-
2008	$-1.88	$0.00	$-5.37M	-
2009	$-0.09	$0.00	$-443.29K	-
2010	$-0.05	$0.00	$-273.4K	-
2020	$0.00	$0.00	$-44.24K	-
2021	$0.00	$0.00	$-167.01K	-
2022	$0.00	$29.44K	$-433.41K	-1472%
2023	$0.00	$45.07K	$1.33M	2950.3%
2024	$0.00	$49.49K	$-632.72K	-1278.6%